RAG2 and plasma cell myeloma: In contrast, osteoblast number did not differ between Pd-1hwtRag2-/- and Pd-1h-/-Rag2-/- mice, suggesting that abrogated osteoclast activity protects Pd-1h-/-Rag2-/- mice from myeloma-induced bone loss (Supplemental Fig. 9).